Arvinas' Grant

Arvinas raised a round of funding on September 26, 2013.

Arvinas (NASDAQ: ARVN) is a pharmaceutical company focused on developing new small molecules aimed at degrading disease-causing cellular proteins. The company is translating these protein degradation …

Articles about Arvinas' Grant: